Trial NCT02318368

View at ClinicalTrials.gov 
Org. Study IDs: AV-299-14-206

Last trial update was posted on 2020-10-22

MeSH Interventions

Erlotinib Hydrochloride

MeSH Conditions

Carcinoma, Non-Small-Cell Lung Lung Neoplasms

Other Conditions

Non-small Cell Lung Cancer

Stopping Reasons

Sponsor's decision

Limitations And Caveats

The Sponsor terminated Study AV-299-14-206 before enrollment was completed, effective 14-Sep- 2016, after determining that enrollment of subjects was much lower than expected, and that timely completion of the study was not feasible.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID